(Q45038149)

8 December 2017

Dose-finding based on efficacy-toxicity trade-offs (English)

1 reference

8 December 2017

0 references

Peter F Thall

1

1 reference

8 December 2017

John D Cook

series ordinal

2

1 reference

8 December 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

8 December 2017

1 reference

8 December 2017

60

1 reference

8 December 2017

684-693

1 reference

8 December 2017

3

1 reference

maintained by WikiProject

8 December 2017

WikiProject Mathematics

0 references

cites work

The bivariate continual reassessment method. extending the CRM to phase I trials of two competing outcomes

1 reference

https://api.crossref.org/works/10.1111%2FJ.0006-341X.2004.00218.X

Approaches for optimal sequential decision analysis in clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0006-341X.2004.00218.X

Simulation as a design tool for phase I/II clinical trials: an example from bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0006-341X.2004.00218.X

A Simplex Method for Function Minimization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0006-341X.2004.00218.X

Continual reassessment method: a practical design for phase 1 clinical trials in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0006-341X.2004.00218.X

A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0006-341X.2004.00218.X

A new statistical method for dose-finding based on efficacy and toxicity in early phase clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0006-341X.2004.00218.X

10.1111/J.0006-341X.2004.00218.X

21 January 2018

Identifiers

DOI

1 reference

8 December 2017

1 reference